Navigation Links
Injection-free vaccination technique could address global vaccine challenge for HIV, malaria
Date:2/4/2013

Scientists at King's College London have demonstrated the ability to deliver a dried live vaccine to the skin without a traditional needle, and shown for the first time that this technique is powerful enough to enable specialised immune cells in the skin to kick-start the immunising properties of the vaccine.

Funded by the Bill & Melinda Gates Foundation and published today in Proceedings of the National Academy of Sciences, researchers say although it is an early study this important technical advance offers a potential solution to the challenges of delivering live vaccines in resource-limited countries globally, without the need for refrigeration. A cheaper alternative to hypodermic needles, it would also remove safety risks from needle contamination and the pain-free administration could lead to more people taking up a vaccination. The researchers add that it could have an impact beyond infectious disease vaccination programmes, for example managing autoimmune and inflammatory conditions such as diabetes.

HIV, malaria and TB represent major global health challenges. Although promising research is underway to develop vaccines for these diseases, considerable stumbling blocks remain for countries where transporting and storing live vaccines in a continuously cold environment (around 2C to 8C or below) would not be possible. If a cold chain cannot be maintained for a live vaccine there is a high risk it could become unsafe and lose effectiveness.

The team at King's used a silicone mould developed by US company TheraJect to create a microneedle array a tiny disc with several micro-needles made of sugar which dissolve when inserted into the skin. The team formulated a dried version of a live modified adenovirus-based candidate HIV vaccine in sugar (sucrose) and used the mould to create the microneedle array. They found that the dried live vaccine remained stable and effective at room temperature.

To test the effectiveness of the microneedle array, they applied it to mice. Using imaging (in collaboration with Professor Frederic Geissmann, King's College London) they observed how the vaccine dissolved in the skin and were able to identify for the first time exactly which specialised immune cells in the skin 'pick up' this type of vaccine and activate the immune system. The researchers found the first evidence that a sub-set of specialised dendritic cells in the skin were responsible for triggering this immune response.

When compared with a traditional needle vaccine method, the immune response generated by the dried microneedle vaccine (kept at room temperature) was equivalent to that induced by the same dose of injected liquid vaccine that had been preserved at -80C.

Dr Linda Klavinskis from the Peter Gorer Department of Immunobiology at King's College London, said: 'We have shown that it is possible to maintain the effectiveness of a live vaccine by drying it in sugar and applying it to the skin using microneedles a potentially painless alternative to hypodermic needles. We have also uncovered the role of specific cells in the skin which act as a surveillance system, picking up the vaccine by this delivery system and kick-starting the body's immune processes.

'This work opens up the exciting possibility of being able to deliver live vaccines in a global context, without the need for refrigeration. It could potentially reduce the cost of manufacturing and transportation, improve safety (as there would be no loss in potency), and avoids the need of hypodermic needle injection, reducing the risk of transmitting blood-borne disease from contaminated needles and syringes.

'This new technique represents a huge leap forward in overcoming the challenges of delivering a vaccination programme for diseases such as HIV and malaria. But these findings may also have wider implications for other infectious disease vaccination programmes, for example infant vaccinations, or even other inflammatory and autoimmune conditions such as diabetes.'


'/>"/>

Contact: Katherine Barnes
katherine.barnes@kcl.ac.uk
44-207-848-3076
King's College London
Source:Eurekalert

Related biology technology :

1. Vaccination reduces the risk of unvaccinated badger cubs testing tuberculosis positive
2. Notre Dame researchers demonstrate new DNA detection technique
3. Research could improve laser-manufacturing technique
4. Clinical technique sets new standard for speed in battle to prevent pandemic infection
5. In new mass-production technique, robotic insects spring to life
6. ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts)
7. Nanosurgery and the fight against cancer: Major breakthrough at Polytechnique Montral
8. Scientists learn how to out run damage with imaging technique
9. New measuring techniques can improve efficiency, safety of nanoparticles
10. Metamaterials may advance with new femtosecond laser technique
11. New imaging technique moves from lab to clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The Foundation ... unique partnerships, seeks outstanding early career nominees for the 2017 New Innovator in ... the needs of a world in which one in nine people suffers from ...
(Date:1/24/2017)... PUNE, India , January 23, 2017 ... "Humanized Mouse Model Market by Type (Genetic, Cell-based (CD34, ... diseases) & End User (Pharmaceutical & Biotech Companies, CRO) ... report studies the global Humanized Mouse Model Market for ... is expected to reach USD 116.0 Million by 2021 ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... company announces significant growth last year adding 65 new US and international facilities ... Army medical centers as well as one of US largest imaging center chains. ...
(Date:1/23/2017)... , January 23, 2017 Atlas Genetics ... completion of its Series D financing, raising $35 million from ... investor, Wondfo Biotech. ... Development of the Atlas Genetics io® system has ... trachomatis (CT) test announced in February 2016.  This new Series ...
Breaking Biology Technology:
(Date:1/12/2017)... 12, 2017 A new report by Allied Market Research, titled, ... biometric technology market is expected to generate revenue of $10.72 billion by 2022, with ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the ...
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., ... iris scanning technology for automotive at CES® 2017. Delta ... GNTX ) to demonstrate the use of iris scanning ... and authenticate the driver in a car, and as ... the driving experience. Delta ID and Gentex ...
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
Breaking Biology News(10 mins):